Phibro Animal Health Corporation

US$32.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PAHCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.54%
Div yield 1.46%
ROE 28.17%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.40
PE TTM 13.18
TSR TTM (20.66%)
Mkt cap US$1.338B
ROIC 12.94%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$40
22.28%
(76.09%)
Hold 7|2|9|11|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.35
0.33
0.37
0.39
22.00%
13.84%
26.76%
23.39%
Revenue$M
68.48
69.81
70.01
74.04
1.81%
6.95%
8.81%
13.44%
Peers (US$1.338B)
Cap (US$)
PE
1.461B
39.91x
1.428B
13.47x
Capital
TTM
5Y
10Y
Leveragex
0.237
1.322
1.122
EBIT/Intx
1.857
0.106
0.100
Own earn%
13.65
(49.79)
(28.59)
Sh yield%
41.40
40.47
44.18
Owners
Insiders/Inst%
4.74
40.54
Short interest%
0.74
SBC / revenue%
5.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
30–36
$1 testx
1.4
Incr. ROIC%
2